Zai Lab
Beaming Xu is a Safety Physician at Zai Lab since September 2023, following an extensive career at Pfizer from March 2012 to April 2023, where roles included Medical Director and Associate Medical Director, focusing on drug safety pharmacovigilance. Prior experience includes serving as a Medical Writer at Pfizer Canada Inc. from July 2009 to December 2010 and as a Safety Assessor at Pfizer China R&D Center from July 2006 to June 2009. Beaming Xu began a medical career as a Resident Gynecologist at the Obstetrics & Gynecology Hospital of Fudan University from July 2004 to June 2006 after earning a Doctor of Medicine (MD) degree in Clinical Medicine from Fudan University between 1999 and 2006.
This person is not in any teams
This person is not in any offices
Zai Lab
5 followers
Zai Lab Ltd is a biopharmaceutical company. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including in the fields of oncology, autoimmune and infectious diseases. The Company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include three drug candidates with greater China rights and three drug candidates with global rights. The greater China rights drug candidates include Niraparib (ZL-2306), Omadacycline (ZL-2401) and ZL-2301. The global rights drug candidates include Fugan (ZL-3101), ZL-2302 and ZL-1101.